Taylor Wealth Management Partners Kala Pharmaceuticals, Inc. Transaction History

Taylor Wealth Management Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$0.61 - $1.84 $11,004 - $33,193	-18,040 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$1.16 - $2.74 $30,101 - $71,103	-25,950 Reduced 58.99%	18,040 $22,000
Q3 2021 Oct 26, 2021	BUY	$2.62 - $5.43 $2,620 - $5,430	1,000 Added 2.33%	43,990 $115,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $26,311 - $42,380	5,200 Added 13.76%	42,990 $228,000
Q1 2021 Apr 21, 2021	BUY	$6.24 - $9.58 $75,816 - $116,397	12,150 Added 47.39%	37,790 $255,000
Q4 2020 Feb 02, 2021	BUY	$6.28 - $8.79 $74,543 - $104,337	11,870 Added 86.2%	25,640 $174,000
Q3 2020 Oct 14, 2020	BUY	$7.5 - $11.11 $103,275 - $152,984	13,770 New	13,770 $103,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

Stay updated on Taylor Wealth Management Partners with notifications on news.